Mycoban

Quick links to important sections

Mycoban

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Mycoban

Understanding Mycoban

Mycoban is a pharmaceutical intervention primarily utilized in the treatment of fungal infections. It belongs to a class of medications known as antifungals, which are designed to target and neutralize specific types of fungal organisms that can affect various parts of the body.

Mechanism of Action

The primary function of Mycoban is to inhibit the growth and reproduction of fungi. It achieves this by interfering with the structural integrity of the fungal cell membrane. Fungal cells rely on a specific compound called ergosterol to maintain their cell walls; Mycoban disrupts the synthesis of this compound, leading to the formation of holes in the membrane. This process causes the cellular contents to leak out, eventually resulting in the death of the fungal cell.

Clinical Applications

Mycoban is commonly indicated for several types of infections, including:

  • Cutaneous Mycoses: Fungal infections affecting the skin, such as athlete's foot or ringworm.
  • Candidiasis: Yeast-like infections that can occur in the mouth, throat, or other mucous membranes.
  • Systemic Fungal Issues: In some formulations, it is used to address more deep-seated infections that have entered the bloodstream or internal organs.

By focusing on the biological differences between human cells and fungal cells, Mycoban is able to target the infection while minimizing impact on the host's healthy tissues. Its use is determined by the specific strain of fungus involved and the location of the infection within the body.

Regulatory References

  1. Clotrimazole and Miconazole Nitrate DailyMed Label

What side effects are possible with Mycoban?

Possible Side Effects and Safety Information

The official regulatory safety profile for this topical dual-azole medicine, containing Clotrimazole and Miconazole Nitrate, is defined primarily by adverse reactions involving Skin and Subcutaneous Tissue Disorders. These reactions occur at the application site and are the most frequently documented effects in official regulatory texts (e.g., FDA, EMA/SmPC).


Documented Adverse Reactions

Side effects commonly listed in regulatory documents include localized symptoms such as a burning sensation, stinging, itching (pruritus), redness (erythema), and general local irritation (NIH DailyMed). Less common reactions may involve a rash, peeling, or edema (swelling) at the application site.

Serious Adverse Reactions and Systemic Concerns

Though generally classified as rare or very rare, the official labeling documents the potential for serious adverse reactions falling under Immune System Disorders. These include hypersensitivity reactions and the risk of anaphylaxis (severe allergic reaction). These severe events warrant immediate discontinuation of the product. The label also notes a high-level safety consequence regarding potential interactions with certain systemic medications, such as oral anticoagulants, due to the miconazole component, which may increase the effects of the anticoagulant (FDA-related regulatory text).


Regulatory Safety Constraints

Specific safety considerations are noted in official labeling. The medicine is contraindicated in individuals with a known allergy or hypersensitivity to its active ingredients or excipients. Furthermore, the product is generally restricted for use in children under 2 years of age unless directed by a healthcare professional, and contact with the eyes must be strictly avoided (NIH DailyMed).

Overdose and Emergency Response

Overdose and when to Seek Help

Official regulatory information for Mycoban (Clotrimazole and Miconazole Nitrate topical) dictates that acute overdosage from topical application is unlikely to cause systemic toxicity or lead to a life-threatening situation. Due to minimal systemic absorption, the primary manifestation from excessive use on the skin is localized skin irritation.

Required Emergency Actions

The regulatory focus for overdose is placed on accidental oral ingestion (swallowing). If Mycoban is accidentally ingested, official labeling mandates that the user seek immediate medical attention or contact a Poison Control Center immediately.

Overdose Context Documented Manifestations
Accidental Ingestion Dizziness, Nausea, Vomiting, Stomach Irritation
Excessive Topical Use Local Skin Irritation/Burning Sensation

Supportive Care and Antidote Status

Official documents describe that for symptomatic accidental ingestion, appropriate supportive care is the required management. Procedures such as gastric lavage should only be considered if significant clinical symptoms become apparent. Regulatory authorities explicitly state that no specific antidote is known to exist for the active ingredients in the event of an overdose.

Therapeutic Uses of Mycoban

Mycoban (which may be part of symptomatic management for conditions involving inflammatory or irritative processes) is primarily used for managing symptoms related to physical discomfort caused by fungal infections. The product is commonly used across domains where additional symptomatic support is needed.


It helps in addressing specific fungal infections of the skin, such as ringworm (tinea corporis), jock itch (tinea cruris), and athlete's foot (tinea pedis). This medication is applied in addressing these types of infections, which are conditions characterized by periods of heightened symptoms (such as redness, scaling, and itching) and create noticeable physiological strain.

In these scenarios, Mycoban contributes to easing the overall symptom load during periods of heightened symptoms. It supports general well-being during symptomatic phases and provides support that helps ease the overall symptom burden when symptoms interfere with routine activities.

“This supportive care is relevant when short-term symptomatic assistance is needed to help patients cope more steadily with symptom fluctuations.”

Quick Fact: Helps with Symptoms related to physical discomfort

Regulatory References

  1. NIH MedlinePlus Drug Information on Miconazole Topical

Eligibility and Restrictions for Use

Who can and cannot use Mycoban?

The eligibility profile for Mycoban, a topical antifungal containing Clotrimazole and Miconazole Nitrate, is defined primarily by absolute allergy restrictions and age-based limitations, as stated in official government regulatory documents.


Contraindications (Who Must Not Use It)

Classification Population/Condition
Absolute Contraindication Individuals with known hypersensitivity or allergy to any Azole antifungal agent (including Clotrimazole or Miconazole Nitrate) or to any of the product’s non-active ingredients.

Age-Related Eligibility

The product's use is officially established for adults and adolescents. Restrictions apply to the youngest populations:

  • Children under two years of age: Use is not recommended unless specifically advised and supervised by a doctor.
  • Infants under four weeks of age: Safety and efficacy have not been established in this age group, according to regulatory labeling.

Special Population Cautions

  • Pregnancy: Use is generally permitted due to minimal systemic absorption, but should only be used if clearly indicated or clearly necessary.
  • Breastfeeding: The product must not be applied directly to the breast or nipple area during lactation to prevent infant contact.

What should I know about interactions with other medicines?

Mycoban Interactions with other medicines and products

Mycoban (containing Miconazole) is a topical antifungal medicine, and while systemic absorption is generally minimal with typical use, clinically significant drug interactions have been documented, primarily stemming from its capacity to inhibit the cytochrome P450 enzyme system (specifically CYP2C9 and CYP3A4) in the liver.

Interacting Product or Class Interaction Mechanism & Outcome Regulatory Context
Coumarin Anticoagulants (e.g., Warfarin, Acenocoumarol) Major Interaction: Miconazole inhibits CYP2C9, significantly reducing the metabolism and clearance of the anticoagulant. This leads to an enhanced anticoagulant effect (high INR) and an elevated risk of severe bleeding. Use with extreme caution/Avoid. Explicit warnings exist for topical, oral gel, and vaginal dosage forms.
Hormonal Contraceptives (e.g., Etonogestrel) Miconazole may reduce the efficacy of rubber contraceptives (condoms, diaphragms) when used in the vulval or genital area, potentially compromising protection against pregnancy. Procedural Restriction. Alternative contraception is advised during and for a period after local use.
Other Topical Products Concomitant use of other skin preparations on the same affected area may influence Miconazole absorption or overall efficacy. General Precaution. Avoid combining with other topical medicines unless directed by a healthcare provider.

Patients on Warfarin must inform their prescribing healthcare provider before starting Mycoban, regardless of the formulation (topical, oral gel, or vaginal), as close monitoring of the International Normalized Ratio (INR) is essential. The potential for interaction with other drugs metabolized by CYP2C9 or CYP3A4 (such as certain oral hypoglycemics, anti-seizure medicines, and immunosuppressants) exists, and concurrent use should be evaluated by a healthcare professional.

Mechanism of Action

How Mycoban Works

The mechanism of Mycoban, a dual-azole combination, involves two complementary biological actions leading to sustained fungal cell destruction, which results in the removal of the biological source that activates local host inflammatory pathways.


Disruption of Fungal Membrane Integrity

The primary effect is achieved by both active agents inhibiting the fungal enzyme lanosterol 14α-demethylase (CYP51). This enzymatic inhibition halts the synthesis of Ergosterol, the stabilizing component of the fungal cell membrane, leading to the accumulation of toxic intermediate sterols. This action directly causes structural failure and increased permeability, resulting in fungal cell death.


Mechanistic Enhancement Through Oxidative Stress

Miconazole Nitrate provides an ancillary mechanism by inhibiting fungal catalase and peroxidase enzymes. This targeted inhibition causes a buildup of Reactive Oxygen Species (ROS) within the fungal cell, adding a layer of oxidative damage that contributes a secondary fungicidal cascade to the primary membrane disruption mechanism.


Removal of the Biological Stimulus for Local Host Response

The combined structural and oxidative attack leads to the structural destruction of the fungal cells. This destruction of the pathogen interrupts the continuity of the biological stimulus that activates local host defense pathways. The resulting cessation of pathogen activity results in the deactivation of the local inflammatory cascade, which is the resulting physiological modulation of the local host response linked to the drug's mechanism.

Dosage and Administration Information

Administration and Frequency

The usage of Mycoban is defined by a standardized protocol for topical administration to address cutaneous infections. The product is exclusively designed for application to the skin and surrounding areas, and is not approved for oral or ocular use. The standard dosing regimen instructs application of a thin layer of the medication twice daily, once in the morning and once in the evening.


Procedural Requirements and Duration

Proper administration requires that the application site be cleansed and thoroughly dried before the medicine is gently rubbed into the skin. The duration of use is fixed according to the specific infection: typically 2 weeks for Jock Itch (Tinea Cruris) and 4 weeks for Athlete's Foot (Tinea Pedis) or Ringworm (Tinea Corporis). It is a standard instruction to continue the application for the full prescribed duration, even if visible symptoms disappear earlier.


Specific Use Parameters

For pediatric use, the same twice-daily frequency and duration apply to children typically 2 years of age and older. A key procedural constraint is the instruction to avoid using occlusive dressings or bandages over the application site unless specifically advised. Due to minimal systemic absorption, no specific dosage adjustments are typically required for individuals with systemic conditions like renal or hepatic impairment when using the topical form. This fixed-schedule protocol governs the precise local delivery of the dual-azole antifungal agents.

Recent Clinical Evidence

Research evidence / Overview of studies

Overview of Research Findings

The research concerning Compound X has centered on its use in chronic inflammatory conditions, especially those affecting the joints. Studies have evaluated Compound X administered alone and in combination with Compound Y.

Compound X has been the subject of several Phase II and Phase III trials. Research has explored whether administration could affect the quality of life in individuals experiencing moderate to severe symptoms. Studies also examined whether administration was associated with changes in the severity of joint pain and morning stiffness over observation periods ranging from 12 to 24 weeks.


Key Study Areas

Administration as a Monotherapy

Early-phase studies focused on exploring potential dosing parameters and how the compound moved through the body. Later research on the compound as a single agent primarily involved individuals who had not previously responded to conventional first-line treatments.

Some initial studies evaluated the time course of observations regarding joint swelling. The research design included comparisons against placebo and active control groups.

Combination with Compound Y

Research evaluated administration of Compound X co-administered with Compound Y. This line of research examined the effects of co-administration.

  • Safety Profile: Studies included monitoring of liver enzyme levels and other potential markers of systemic exposure.
  • Tolerability: Tolerability findings were frequently noted across the study cohorts.
  • Study Endpoints Related to Structure: Research has examined whether the combination was associated with changes in bone density in longer-term trials.

Clinical Practice Considerations

Study protocols have included observation of drug-drug interactions, particularly with immunosuppressants.

Research examined administration alongside or in comparison to other compounds commonly used in managing inflammation. Furthermore, research has explored long-term effects in observational cohorts after the main trial periods concluded. Research has examined the impact on progression in sub-groups of patients with confirmed joint erosion.

Key Studies & References

  1. Efficacy of Curcuma longa in relieving pain symptoms of knee osteoarthritis patients: a systematic review and metaanalysis of clinical trials

Frequently Asked Questions (FAQ)

Common questions about Mycoban (FAQ)

Q: How quickly does Mycoban start working after taking it?

A: Official regulatory labels indicate that Mycoban relieves associated symptoms like itching and burning early in the course of treatment. Official protocols describe the use of a full course of treatment to address the infection.

The product information indicates symptom improvement is generally observed within 2 weeks for infections like jock itch or 4 weeks for athlete’s foot. If symptoms show no improvement after these periods, a healthcare professional should be consulted, as described in official guidance.

Q: What happens if I miss a scheduled dose of Mycoban?

A: Official instructions emphasize the importance of using the medication regularly and not missing doses to support the goal of clearing the infection. If a dose is missed, regulatory guidance describes applying it as soon as it is remembered. After that, the twice-daily schedule is continued.

Q: Can Mycoban cause upset stomach or nausea?

A: Because Mycoban is a topical medication applied to the skin, minimal amounts are absorbed into the body. Due to this low systemic absorption, official regulatory documents do not commonly list generalized side effects like upset stomach or nausea for the cream, solution, or powder forms.

Q: Is a headache a known side effect of Mycoban?

A: Official safety information for topical Mycoban focuses primarily on local skin reactions at the application site, such as burning or irritation. Headache is not typically listed among the common side effects reported in the regulatory safety profile for this topical antifungal.

Q: Does Mycoban make a person feel tired or drowsy?

A: The topical application of Mycoban leads to minimal absorption into the bloodstream. Because of this, official regulatory information does not list systemic effects such as feeling tired or drowsy among the commonly reported side effects.

Q: Are there specific vitamins or supplements that should not be taken with Mycoban?

A: Official labeling provides general warnings about potential interactions with certain systemic medications. However, no specific warnings are provided for vitamins or common dietary supplements when using the topical form. Official guidance emphasizes reviewing all concurrent use with a healthcare provider.

Q: Can taking Mycoban affect my blood pressure?

A: The topical form of Mycoban has minimal systemic absorption into the body. For this reason, official regulatory documents do not list changes in blood pressure as a known or common side effect of the medication.

Q: Does alcohol consumption need to be avoided while using Mycoban?

A: Regulatory information for the topical form of Mycoban does not contain any explicit contraindications or warnings regarding the consumption of alcohol during its use.

Q: Is Mycoban a prescription-only medicine?

A: The active ingredients in Mycoban (topical miconazole and clotrimazole) are widely available as Over-The-Counter (OTC) medications. This means they can typically be purchased without a prescription.

Q: Can Mycoban change the taste of foods or drinks?

A: Because Mycoban is only applied externally to the skin, it is not absorbed into the body in amounts significant enough to cause changes in your sense of taste. This is typically only a concern with medications taken by mouth.

Q: Are there any long-term effects associated with Mycoban use?

A: Official regulatory guidelines describe the medication's use for short-term treatment durations, typically up to four weeks. The long-term effects or consequences of using the medication beyond the recommended duration have not been fully established in regulatory documents.

Q: What is the main conclusion of the clinical research on Mycoban?

A: Clinical research evidence supports the product’s use in the treatment of common superficial fungal infections. The research evidence describes its benefit in addressing infections such as athlete's foot, jock itch, and ringworm when used according to the established protocol.

Q: Were there large studies done to establish the effectiveness of Mycoban?

A: Yes, the product's regulatory approval is based on clinical data. Official information confirms that studies were conducted to provide evidence supporting the product’s approved uses and safety profile.

Q: Is Mycoban considered a new drug or has it been around for a while?

A: The active ingredients in Mycoban, Miconazole Nitrate and Clotrimazole, are well-established antifungal agents. These compounds have been in use for several decades and are commonly available in various generic forms.

Q: Does Mycoban affect blood sugar levels?

A: Changes in blood sugar levels are not listed as a known or common systemic side effect for the topical application of this medication. Its use on the skin does not typically result in significant systemic absorption.

Q: Are there any dietary restrictions mentioned for people taking Mycoban?

A: Official regulatory documents do not mention any specific dietary restrictions or requirements for people using this topical medication.

Q: Can Mycoban affect sleep patterns?

A: Adverse events related to sleep or insomnia are not commonly reported in the regulatory safety profile of this topical medication, which is due to its minimal absorption into the body.

Q: Is it safe to drive or operate machinery while taking Mycoban?

A: Official safety assessments indicate no expected effect on the ability to drive or operate machinery. This is because the topical form has minimal systemic absorption and no listed effects on concentration or consciousness.

Q: What information is available about Mycoban in official FDA documents?

A: Official documents, such as the product's DailyMed label from the FDA, contain comprehensive factual information. This includes approved uses, directions for application, known side effects, active ingredients, warnings, and drug interactions.

Q: Does Mycoban cause sensitivity to sunlight?

A: Increased sensitivity to sunlight (photosensitivity) is not generally listed as a common or required warning in the regulatory labeling for the topical form of this medication.

Q: Is there a generic version of Mycoban available?

A: Yes, generic versions of the active ingredients, Miconazole Nitrate and Clotrimazole, are widely available. These generic antifungal products are approved for the same uses.

Q: Is it true that Mycoban can affect gut flora?

A: Since Mycoban is a topical medication with minimal systemic absorption, official information does not indicate that it significantly affects the bacterial flora in the gut.

Q: Does Mycoban affect the results of any common lab tests?

A: Regulatory warnings note that the Miconazole component can interact with systemic blood thinners like warfarin. This interaction may make monitoring of coagulation tests necessary.

There are no general warnings for interference with routine laboratory tests.

Q: Is there a risk of dependency or addiction with Mycoban?

A: Official regulatory classification confirms that Mycoban is not a controlled substance. It carries no known risk of physical dependence or addiction.

Q: Is Mycoban used for preventative purposes?

A: The medication is indicated for treating established infections and is not approved for prevention. Official product labeling specifies its use for the treatment and cure of existing fungal infections.

Q: Is Mycoban a type of antibiotic?

A: No, Mycoban is formally classified in regulatory documents as an antifungal medication. Its mechanism is designed to treat infections specifically caused by fungus, not bacteria.

Q: Why is Mycoban sometimes called a 'broad-spectrum' medicine?

A: Regulatory documents refer to Mycoban as 'broad-spectrum' because its dual-azole composition is described as being active against a wide range of different types of fungi and yeasts. This includes the pathogens that cause athlete's foot, jock itch, and ringworm.

Q: How long does the effect of one dose of Mycoban last?

A: The standard regulatory instruction is to apply the medicine twice daily, once in the morning and once at night. This frequency is designed to maintain effective levels of the medication in the skin for approximately 12 hours between applications.

Q: Can Mycoban be taken with food, or should it be on an empty stomach?

A: Official administration instructions specify that Mycoban is applied topically (to the skin). Since it is not swallowed or taken by mouth, there are no instructions related to food or an empty stomach.

Q: Is it okay to crush or split Mycoban tablets?

A: The official dosage forms for this product include a cream, solution, powder, or gel, and not an oral tablet. The product is designed for external use on the skin.

Q: Does Mycoban interact with common pain relievers like ibuprofen?

A: The potential for interaction is primarily with medications that are metabolized by the CYP2C9 or CYP3A4 enzyme systems in the liver. Although a direct warning is not commonly cited, official guidance suggests reviewing all concurrent medications with a healthcare provider.

Q: Does Mycoban interact with hormonal birth control pills?

A: Miconazole, one of the active ingredients, may have the potential to alter the blood levels of certain hormones found in combined oral contraceptives. The primary official warnings, however, relate to the physical damage the topical product may cause to rubber contraceptives (diaphragms or condoms).

Q: Does Mycoban help with viral infections like the common cold?

A: No, Mycoban is classified as an antifungal medication in official regulatory documents. It is not indicated for treating infections caused by viruses, such as the common cold.

Q: What happens if Mycoban is taken for too long?

A: Official regulatory guidelines state that the safety of using the medication beyond the specified treatment duration (either 2 or 4 weeks) is not fully established. Use past the recommended time should only occur under the guidance of a healthcare professional, as described in official warnings.

Q: What kind of monitoring is typically done while a person is taking Mycoban?

A: For most individuals, no routine monitoring is typically required. However, official warnings note that if a person is using the blood thinner warfarin concurrently, close monitoring of blood clotting tests (like INR) may be necessary due to a known drug interaction.

Q: What should be done if I experience an allergic reaction to Mycoban?

A: Official warnings state that if signs of a serious allergic reaction, such as swelling of the face, throat, or tongue, or difficulty breathing, occur, the medication must be immediately discontinued. For severe symptoms, official guidance describes seeking emergency medical attention.

How should Mycoban be stored and disposed of?

Storage and Disposal of Mycoban

Mycoban (topical miconazole) must be stored at a controlled room temperature, typically between 15 C and 30 C (59 F and 86 F), according to official regulatory documentation. The product must be shielded from freezing, excessive heat, moisture, and direct light.

Container and Protection Rules

For stability, the medicine must be kept in the container that it came in, and the cap must be maintained tightly closed. Consistent with all medical products, Mycoban must be kept out of the reach of children to prevent accidental exposure.

Disposal Requirements

Unused or expired Mycoban should be disposed of via a drug take-back location if available. If not, the product must be mixed with an undesirable substance (such as dirt) in a sealed container and placed in the household trash; the medicine must not be flushed down the toilet or poured down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Mycoban found in:

A-Z Index: